BENTAZON-MCPA EFFECT ON Fusarium oxysporum ROOT ROT ON Trifolium pratense IN GREENHOUSE CONDITIONS
In Chile, the main factor in red clover {Trifolium pretense L.) stand decline is fusarium-root rot, which results in a reduction in yield. Fusarium oxysporum (Schlect.) is the most prevalent pathogen recovered from diseased red clover roots plants. Agronomical management of red clover includes appli...
Guardado en:
Autores principales: | , , , , |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad Chilena de la Ciencia del Suelo
2009
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-27912009000200006 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sumario: | In Chile, the main factor in red clover {Trifolium pretense L.) stand decline is fusarium-root rot, which results in a reduction in yield. Fusarium oxysporum (Schlect.) is the most prevalent pathogen recovered from diseased red clover roots plants. Agronomical management of red clover includes application of broadleaf herbicides such as MCPA and bentazon. This study was conducted to evaluate the effects of bentazon and bentazon/MCPA mixture on phytotoxicity and root rot as caused by F. oxysporum on red clover, under greenhouse conditions. In addition, in vitro mycelial growth and conidial germination of F. oxysporum was studied. A reduction of 40% in crown diameter and 57% shoot dry weight was observed 30 days after treatment with a high rate of bentazon/MCPA and F. oxysporum inoculum. The bentazon - F. oxysporum interaction reduced root dry weight by 57% at IX rate and 42% with 2X rate at 20 and 30 of evaluation. Bentazon caused a significant increase in phytotoxicity at the high rate and the mixture bentazon/MCPA increased root rot severity and phytotoxicity at the high rate. The conidial germination and mycelial growth were significantly reduced by bentazon/MCPA. These results suggest that red clover growth and persistence could be adversely affected by F. oxysporum after bentazon and bentazon/MCPA application. |
---|